Background {#Sec1}
==========

Hepatocellular carcinoma (HCC) with tumor thrombus (TT) in the right atrium is a critical condition \[[@CR1]\]. There is no standard treatment strategy, and surgery is challenging. The median survival is reported to be from 1 to 4 months, and it may be complicated by lung metastasis, pulmonary embolism, heart failure, and sudden cardiac death \[[@CR1], [@CR2]\]. There are no effective nonsurgical treatments, and while long-term survivors have been reported after surgery, surgical mortality is reported to be 15% \[[@CR1]--[@CR5]\]. The general consensus is to perform hepatectomy prior to cavo-atrial thrombectomy, because of the risk of uncontrollable bleeding during the subsequent transection of the liver after heparinization \[[@CR6]\]. However, cavo-atrial thrombectomy prior to hepatectomy should be considered in cases with TT which fully enters the right atrium, reaches the tricuspid valve, and is of the pedunculated type, in order to prevent the ball-valve effect or pulmonary embolism \[[@CR2]\].

Case presentation {#Sec2}
=================

The patient was a 75-year-old woman who presented with severe bilateral leg edema and epigastralgia. There was no past history of chronic hepatitis or blood transfusion. Admission laboratory tests revealed an elevated serum aspartate aminotransferase level (48 U/L), mildly decreased serum albumin (3.6 g/dL), mildly decreased serum [prothrombin time](https://ejje.weblio.jp/content/prothrombin+time) (74%), mildly elevated D-dimer (12.9 μg/mL), and mildly elevated fibrin degradation product (12.6 μg/mL). The tumor marker AFP was slightly elevated to 585 ng/mL. The Child-Pugh classification was A, and the indocyanine green retention rate at 15 min was 12%. CT scans showed a huge tumor, 21 cm in diameter, in the right liver and TT, 37 mm in diameter, in the right atrium (Figs. [1a, b](#Fig1){ref-type="fig"} and [2](#Fig2){ref-type="fig"}a). The TT was pedunculated, swung like a pendulum with the heartbeat, and reached the tricuspid valve on a transesophageal ultrasound video (Fig. [2](#Fig2){ref-type="fig"}b). The symptomatic patient had a risk of sudden death due to TT in the right atrium. Therefore, we explained the high surgical mortality rate to the patient and her family, and they decided to proceed with surgery.Fig. 1CT showed a huge tumor, 21 cm in diameter, in the right liver (**a**). The tumor compressed the middle hepatic vein (arrowhead) and inferior vena cava (arrow) (**b**)Fig. 2CT showed a tumor thrombus in the right atrium (**a**, arrow). The tumor thrombus moved with the heartbeat and reached the tricuspid valve on transesophageal ultrasound (arrow) (**b**)

At first, a partial sternotomy was made, and cardiopulmonary bypass (CPB) via the aorta, superior vena cava, and right femoral vein and electrical ventricular fibrillation were performed after intravenous injection of 25,000 units of heparin sodium. Although the TT in the right atrium was very soft and fragile, thrombectomy from the right atrium and inferior vena cava (IVC) was successful (Fig. [3](#Fig3){ref-type="fig"}a--d). After the removal of TT, the IVC was clamped with a tourniquet above the diaphragm and the right atrium was sutured with 5--0 Prolene. After DC defibrillation was carried out, CPB was stopped, the tourniquet on the IVC was released, and 100 mg protamine was administered for the neutralization of heparin. The open heart surgery time was 23 min, and the CPB time was 42 min. Next, a reverse T incision was made, and right hepatectomy by anterior approach and IVC tumor thrombectomy were performed. After ligation of the anterior and posterior Glissonean pedicles, the liver parenchyma was transected under the Pringle maneuver and IVC clamping below the liver. After the IVC and right hepatic vein were confirmed by anterior approach, the IVC was opened and a residual TT in the IVC was removed under total hepatic vascular exclusion (THVE) (Fig. [4](#Fig4){ref-type="fig"}a--d). Finally, the huge tumor was removed with the diaphragm without pulmonary embolism. The total operation time was 9 h, and the total blood loss was 8200 mL. The tumor was of the massive type macroscopically (Fig. [5](#Fig5){ref-type="fig"}), and cancer cells showed moderately to poorly differentiated HCC with invasion to the portal vein, hepatic vein, and diaphragm. The patient's postoperative course was uneventful, and she was discharged 14 days after surgery. She is still alive 14 months after surgery with recurrence in the lung.Fig. 3Tumor thrombectomy in the right atrium under electrical ventricular fibrillation and cardiopulmonary bypass (CPB) was performed after intravenous injection of heparin sodium (**a**, **b**). The TT in the right atrium was removed from the right atrium without pulmonary embolization (**c**, **d**). The open heart surgery time was 23 minFig. 4Right hepatectomy by anterior approach (**a**, **b**) and IVC tumor thrombectomy were performed under total hepatic vascular exclusion after neutralization of heparin (**c**, **d**)Fig. 5The tumor showed a massive type macroscopically and HCC invaded to the diaphragm (**a**, **b**)

Discussion {#Sec3}
==========

The general consensus is to perform hepatectomy prior to cavo-atrial thrombectomy, because of the risk of uncontrollable bleeding during the subsequent transection of the liver after heparinization. However, in cases of a large TT which enters the right atrium, reaches the tricuspid valve, and is of the pedunculated type, sudden cardiac arrest due to the ball-valve effect and pulmonary embolism have been reported. Therefore, cavo-atrial thrombectomy prior to hepatectomy should be considered as one of the options for HCC with TT in the right atrium \[[@CR1]--[@CR6]\].

Tsang et al. reported a case of HCC with TT in the right atrium treated with combined cavo-atrial thrombectomy and hepatectomy \[[@CR2]\]. According to their report, liver transection by the anterior approach was carried out before thrombectomy. However, hepatectomy was converted to thrombectomy because unstable hemodynamics and uncontrollable bleeding (blood loss was 30 L) developed as a result of right ventricular inflow obstruction secondary to the ball-valve effect. In our present case, cavo-atrial thrombectomy prior to hepatectomy was performed to prevent the ball-valve effect or pulmonary embolism because the TT swung like a pendulum with the heartbeat on a transesophageal ultrasound video. Transesophageal ultrasound video of a TT is useful for deciding to perform cavo-atrial thrombectomy prior to hepatectomy.

Sakamoto and Nagano classified TT in the IVC and/or right atrium into type I--III, and the intracardiac type (type III) requires hepatectomy plus thrombectomy under CPB. There have been 14 previous reports of cases in which HCC with TT in the right atrium was successfully removed with hepatectomy prior to thrombectomy and CPB by collaboration of cardiovascular surgeons and gastroenterological surgeons (Table [1](#Tab1){ref-type="table"}) \[[@CR3], [@CR7]\]. According to the reports, eight patients had no complications after surgery. However, one patient developed DIC, one patient had bleeding, and two patients had pleural effusion after surgery. Wakayama et al. reported six cases of HCC with TT in the right atrium treated with hepatectomy prior to thrombectomy with CPB, two cases had controllable complications, but there was no surgical mortality \[[@CR4]\]. At our institute, six patients with HCC and TT in the right atrium underwent hepatectomy prior to thrombectomy with or without CPB between 1986 and 2001. Three of six patients died of sudden cardiac arrest during surgery. We therefore stopped surgery for HCC with atrial TT since 2001.Table 1Reports of cases with HCC and tumor thrombus in the right atriumAuthorYearAge/sexSize of HCCSize of TTLiver or heart surgery firstHepatectomyCPB or THVECardiac arrestTemperatureHeparinBlood lossOperation timeComplicationSurvivalRecurrenceOnitsuka199059/male15N.D.Liver firstLeft HRCPBArrestHypothermiaN.D.N.D.N.D.N.D.7 months aliveNoTsuzuki199157/male55.2Liver firstS4CPBNo arrestNormal3 mg/kg672013 h 52 minDIC5 months deadLiverFujisaki199138/female8.5N.D.Liver firstLeft HRCPBArrestHypothermiaN.D.940014 h 54 minNo15 months aliveNoSano199959/male10N.D.Liver firstRight HRWithout CPB, THVE14,3218 h 20 minNo56 months deadLiverOzeki200070/male113Liver firstRight HRWithout CPB, THVE34509 h 10 minNo26 months aliveNoYokoi200054/male77Liver firstLeft HRCPBN.D.N.D.3000 U/kg14,0008 h 55 minBleeding12 months aliveLiver, boneWu200042/male1.515Liver firstPartial resectionCPBArrestHypothermiaN.D.700011.2 hNo14 months deadLung, boneYogita200061/male5N.D.Liver firstLeft HRCPBNo arrestN.D.0.3 mg/kg291011 h 20 minNo56 months deadLungMiyazawa200455/male74Liver firstRight HRCPBN.D.N.D.N.D.45006 h 30 minNo12 months aliveNoSugimoto200455/male14N.D.Heart fiirstLeft HRCPBNo arrestN.D.N.D.37358 h 20 minNo11 months aliveLiver, lungUemura200460/male5N.D.Liver firstRight HRWithout CPB, THVEN.D.545 minNo14 months aliveNoTani200668/male103.5Liver firstRight HRCPBN.D.N.D.N.D.27507 h 29 minNo11 months aliveLiverLin200757/male4.5N.D.Liver firstRight HRN.D.N.D.N.D.N.D.N.D.N.D.Multiple organ failure, dead3 days deadN.D.Florman200955/male185Liver firstLeft HRCPBArrestN.D.N.D.N.D.6 hNo3 months aliveNoLeo201045/maleN.D.N.D.Liver firstLeft HRCPBHeart fibrillatedHypothermiaN.D.N.D.N.D.Pleural effusion6 months aliveLungKyokane201064/female2.25Liver firstRight HRWithout CPB, V-V bypass771411 h 35 minNo24 months aliveLungInoue201172/male53Liver firstLeft HRCPBNo arrestN.D.7000 U418013 h 25 minNo27 months aliveNoLi201264/male5.3N.D.Liver firstPosterior sectionectomyCPBArrestN.D.N.D.11,000405 minNo6 months deadLiver44/male10.7N.D.Liver firstLeft HRCPBNo arrestN.D.N.D.1200360 minPleural effusion38 months deadLiverLi201340/male10N.D.Liver firstRight HRCPBN.D.N.D.N.D.1200N.D.N.D.10 months deadN.D.Li201466/male12N.D.Liver firstRight HRWithout CPB, THVE8003 hNo6 months deadPresent, N.D.Ishino201569/male123Liver firstRight HRWithout CPB, THVE12006 h 22 minNo24 months aliveNoTsang201747/male19.65.8Liver firstRight HRCPBNo arrestN.D.N.D.30,000N.D.No7 months aliveLung*HCC* hepatocellular carcinoma, *N.D.* not described, *HR* hepatic resection, *CPB* cardiopulmonary bypass, *THVE* total hepatic vascular exclusion

Recently, hepatectomy prior to thrombectomy without CPB has been attempted. There have been five previous reports of cases in which HCC with TT in the right atrium was successfully removed without CPB (Table [1](#Tab1){ref-type="table"}) \[[@CR3], [@CR7]\]. According to these reports, no complications or no mortality have been reported. When a TT is excluded from the right atrium after complete mobilization and caudal retraction of the liver, thrombectomy can be done with total hepatic vascular exclusion without CPB. Hepatectomy prior to thrombectomy without CPB was performed in a 77-year-old man with HCC and TT in the right atrium at our institute in 2016. However, a pulmonary embolism due to TT developed in the left pulmonary artery. He died of multiple lung metastases 5 months after surgery. Therefore, hepatectomy prior to thrombectomy carries a risk of sudden cardiac arrest and pulmonary embolism during surgery.

Sugimoto et al. first reported upfront cavo-atrial thrombectomy followed by hepatectomy to prevent sudden death or pulmonary embolism, and there have been no other reports to the best of our knowledge \[[@CR8]\]. According to their Japanese report, thrombectomy prior to left hepatectomy was successfully performed without uncontrollable bleeding (blood loss was 3735 mL). In our present case, most bleeding occurred during liver surgery (blood loss was 8200 mL) due to heparinization. Thrombectomy prior to right hepatectomy will prevent uncontrollable bleeding due to inflow obstruction by the ball-valve effect.

For open heart surgery, heparin, cardiac arrest, hypothermia, and cardioplegia under CPB are required. Recently, cardiac surgery has been improved and open heart surgery with beating heart has become possible, removing any limitation of open heart surgery with beating heart. If the TT reaches the right ventricle, thrombectomy will be possible. For liver resection, major hepatectomy such as right or left hepatectomy was required because the size of HCC was huge and the TT also involved the right, middle, or left hepatic vein. In cases of HCC with TT in the right liver, the anterior approach to the IVC or RHV is recommended because this anterior approach is safe for huge HCC in the right liver.

In liver surgery for patients with HCC, safe and oncological management is important. Thrombectomy prior to hepatectomy requires cutting the TT in the IVC. This procedure may induce lung metastasis, and lung metastasis did occur in Sugimoto's and our patient. However, the rate of lung metastasis is also very high after hepatectomy prior to thrombectomy. Five of 22 cases in previous reports had lung metastasis after hepatectomy prior to thrombectomy. Wakayama et al reported that not only all six patients with TT in the right atrium but also six of seven patients with TT in the IVC had lung metastasis \[[@CR4]\]. Furthermore, recent advanced molecular target therapy for lung metastasis is quite effective. Therefore, safe management is more important for patients with HCC and TT in the right atrium.

Conclusions {#Sec4}
===========

This is the first English-language report on cavo-atrial thrombectomy prior to hepatectomy. Cavo-atrial thrombectomy prior to hepatectomy for HCC with TT in the right atrium can be performed safely to prevent sudden cardiac arrest and pulmonary embolism. When a large TT is located in the right atrium and/or is of the pedunculated type, in which case there is a concern for sudden cardiac arrest and pulmonary embolism, cavo-atrial thrombectomy prior to hepatectomy is recommended.
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